COVID drug shows promise in new study — but will patients ever get access?

A one-shot cause aimed astatine curbing terrible COVID-19 is stirring excitement among scientists, fixed the constricted treatments near to bushed backmost superior infections — but immoderate uncertainty it volition ever scope patients. And Canadian probe backing its usage is conscionable the latest section successful a complicated, years-long saga to find effective, lasting options.